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Background: CFTR expression studies contribute in understanding the relationship between CFTR transcripts and clinical outcomes.
Normalization of qPCR data is an essential step to determine target gene expression. Consequently, appropriate reference genes must be selected
for each gene/tissue. In this work, we have assessed the suitability of four potential reference genes for CFTR expression analysis in nasal
epithelium.
Methods: B2M, GUSB, HPRT1 and ATP2B4 expression was evaluated in nasal epithelium samples (CFTR-wt controls, n=21; CFTR-splicing
group, n=18) by RT-qPCR. Calibration curves were built and different analyses (geNorm, NormFinder, Mann–Whitney) were performed to
evaluate gene expression stability between samples as well as between groups.
Results and conclusions: We have applied an accurate approach to select reference genes for CFTR expression analysis in nasal epithelium. From
the four genes assessed, GUSB and ATP2B4 have been validated as a reliable gene combination for CFTR gene qPCR data normalization.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; CFTR; Gene expression; Nasal epithelium; Reference gene; RT-qPCR1. Introduction
Cystic fibrosis (CF; OMIM 219700) is a multi-systemic
disease caused by CFTR gene mutations (ABCC7; OMIM
602421) which mainly affect ion transport at the epithelial tissues.
Transcript amount has been associated with a broad phenotypic
spectrum fromCF toCFTR-related disorders [1]. To determine the
clinical relevance of CFTR expression level, several approaches
have been developed providing transcript quantification of normal
and mutant alleles in different tissues [2–5].⁎ Corresponding author at: Human Molecular Genetics Group, Bellvitge
Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Gran Via
de l'Hospitalet, 199, 08908 Barcelona, Spain. Tel.: +34 93 260 74 25; fax: +34
93 260 74 14.
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doi:10.1016/j.jcf.2012.03.008In recent years, reverse transcription-quantitative polymerase
chain reaction (RT-qPCR) has become increasingly relevant
because of its capacity to determine the expression level of a target
gene in different sample types [6]. Its simplicity, specificity and
sensitivity make RT-qPCR the most suitable quantitative method
for gene expression analysis [7,8]. However, some factors related
to biological and technical variability, such as differences in RNA
starting material, PCR efficiency, reverse transcription enzymatic
efficiency or different tissue and cell transcriptional activity, may
lead to seriousmisinterpretation of results [9–11]. Regarding these
variables, recent guidelines have been published to minimize their
effect [7].
In particular, the use of reference genes is commonly
accepted as the most appropriate strategy for data normalization
[6,12,13]. An ideal reference gene must be stably expressed,
non-regulated and not affected by biological or experimental
conditions [14]. So far, the published data suggest that there areby Elsevier B.V. All rights reserved.
399L. Masvidal et al. / Journal of Cystic Fibrosis 11 (2012) 398–404no genes whose expression is universally stable across all types
of tissue and/or condition [11]. Therefore, it is critical to
perform a previous evaluation study aimed at identifying the
most appropriate reference genes for each target gene and
experiment.
Currently, most of the CFTR cDNA analysis is performed
on nasal epithelial (NE) cells, due to their CFTR expression and
easy harvesting. In this study, we have evaluated four candidate
reference genes to select the most reliable ones to normalize
CFTR qPCR data for gene expression studies in NE cells. The
major challenges of this work have been the low CFTR gene
expression and the limited amount of NE cells for ex vivo
analysis.
2. Material and methods
2.1. Samples
Three sample types were analyzed in this study: 1) The
Human Embryonic Kidney 293 cell line over-expressing wild
type CFTR cDNA (HEK 293-CFTR); 2) a nasal polyp (NP)
from a p.Phe508del homozygous CF patient; and 3) NE
samples from 39 adult individuals, CFTR-wild type controls
(n=21) and CFTR-splicing group (n=18). All individuals in
the second group bore the same class V splicing mutation
associated with CF. Class V mutations show a lower amount of
full length transcripts and differences in expression level have
been reported concerning different class V mutations [2–5].
Consequently, full length CFTR transcripts are expected to be
lower in the CFTR-splicing group. No other significant
differences were expected as p.Phe508del causes a misfolded
protein (class II). All participants gave their written consent and
the study was approved by the local ethics committee.
HEK 293 cell line culture and cell transfection with the
pCMVCFTRNot6.2 expression vector carrying the 6.2 kb
human wild type CFTR cDNA were carried out as previously
described [15]. Cells were collected in RNA lysis buffer
(Stratagene Agilent Technologies, Waldbronn, Germany) 48 h
post-transfection and stored at −20 °C until processing.
NP was excised and frozen in liquid nitrogen immediately.
NE cells were collected using a cytology brush (Eurogine S.L.,
Spain). Brushes were placed directly in 1 ml RNAlater buffer
(Qiagen, Hilden, Germany). RNAlater maintains RNA integrity
and allows a homogeneous process for all samples while stored
at 4 °C overnight, and frozen at −80 °C until processing.
2.2. Total RNA isolation and cDNA synthesis
Total RNA was extracted using Absolutely RNAMiniprep Kit
(Stratagene Agilent Technologies, Waldbronn, Germany),
according to manufacturer's instructions. Samples were treated
with DNase to prevent genomic DNA interference. RNA quantity
and quality were first measured in a NanoDrop ND-100
(Nanodrop Technologies, Montchanin, DE, USA). Furthermore,
the integrity of RNA was assessed using the Agilent 2100
Bioanalyzer (Agilent Technologies, Waldbronn, Germany) which
provides the RNA integrity number (RIN) (scores range from 10to 1, the former being the highest RNA quality) [16], and 260/
280 nm ratio values. To reduce RNA variability from NE
samples, we established several threshold inclusion parameters:
a) RNA concentration≥50 ng/μl; b) 260/280 nm ratio≥1.90;
and c) RIN≥5. No significant differences in RIN values were
found between groups (CFTR-wild type 6.12±0.78, CFTR-
splicing 6.10±0.61, p=0.90).
For cDNA synthesis, RNA samples were denatured for
5 min at 65 °C and cooled on ice. RNA samples (500 ng) used
in this study were simultaneously reverse transcribed (RT) in a
20 μl reaction mixture using the High-capacity cDNA reverse
transcription kit and random primers (Applied Biosystems,
Foster City, CA, USA) according to the protocol. Duplicated
RT reactions were carried out for each sample. In addition, a
pool of all control samples was additionally obtained as an
extra sample before RT to create calibration curves. cDNAs
were stored at −20 °C until RT-qPCR experiments were
performed.
2.3. Candidate reference genes
Four candidate reference genes were selected from the
literature: Beta-2-microglobulin (B2M), Glucuronidase-beta
(GUSB), Hypoxanthine phosphoribosyltransferase 1 (HPRT1)
and Plasma membrane Ca++-transporting ATPase 4 (ATP2B4;
PMCA4). It is worth noting that, unlike commonly used
reference genes, we have included in this study the ATP2B4
gene [17] encoding a membrane protein as CFTR does. The
four genes have independent functions in cellular maintenance
and, regulation of their expression is assumed not to be directly
related (Table 1).
2.4. qPCR
qPCR analysis was performed on an ABI 7300 real-time
PCR system (Applied Biosystems, Foster City, CA, USA)
using pre-designed cDNA specific Taqman™ assay-on-
demand products (Table 1). Reactions were carried out in a
total volume of 20 μl containing 10 μl Universal Master Mix
No UNG 2× (Applied Biosystems, Foster City, CA, USA), 1 μl
Taqman™ assay (20×), 8 μl RNase-free water and 1 μl cDNA.
PCR universal conditions were, 10 min template denaturation
at 95 °C and 40 cycles with a denaturation at 95 °C for 15 s,
and a combined primer annealing/elongation at 60 °C for
1 min. Triplicate reactions were carried out for each sample/
gene combination. No RT and no RNA samples were included
to test for PCR and genomic DNA contamination, respectively.
Furthermore, a calibrator sample was included in every run to
correct for inter-run variability.
Four points of a 5-fold serial dilution were created from the
control pool sample and used to build a calibration curve for
each gene. Triplicate reactions were also carried out. For each
calibration curve a correlation coefficient was generated (R2)
and used as a goodness of fit. Amplification efficiency was
obtained using the following equation: E=10(−1/slope), where E
is the PCR efficiency and “slope” is the slope of the regression
line generated. An E value of 2 corresponds to the maximum
Table 1
The four candidate reference genes and CFTR target gene characteristics.
Gene name Symbol Accession num. Function Location Assay a
Beta-2-microglobulin B2M NM_004048 Beta-chain of major histocompatibility
complex class I molecules
15q21-q22.2 Hs00984230_m1
Glucuronidase, beta GUSB NM_000181 Glycosaminoglycans degradation 7q21.11 Hs99999908_m1
Hypoxanthine phosphoribosyltransferase 1 HPRT1 NM_000194 Purine synthesis in salvage pathway Xq26.1 Hs01003267_m1
ATPase, Ca++ transporting, plasma membrane 4 ATP2B4 NM_001684 Calcium transmembrane transport 1q32.1 Hs00608066_m1
Cystic fibrosis transmembrane conductance regulator CFTR NM_001104950 Chloride transmembrane transport 7q31.2 Hs00357011_m1
a ABI gene expression assay ID (Applied Biosystems).
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determined using SDS software v1.3.1 (Applied Biosystems,
Foster City, CA, USA) and a manual threshold among
triplicates was applied for all genes at 0.200.
To confirm reproducibility and precision of real time
experiments, intra-assay and inter-assay variation from the
raw Cq values were determined for all samples (n=39).
Variation was measured as the coefficient of variation (CV)
of Cq values. The CV intra-assay ranges were 0.04–1.05 (RT1)
and 0.06–1.08 (RT2) for GUSB; 0.03–1.05 (RT1) and 0.05–
1.18 (RT2) for ATP2B4; and 0.05–0.78 (RT1) and 0.05–1.21
(RT2) for HPRT1, covering over 90% of the analyzed samples.
In addition, the CV inter-assay (RT1 vs. RT2) ranges were
0.01–3.81 for GUSB, 0.11–2.63 for ATP2B4 and 0.12–5.73 for
HPRT1, in the 90% of samples (Fig. 1).
For each RT-qPCR experiment, Cq values were converted to
relative quantities (RQ) and subsequently to calibrated
normalized relative quantities (CNRQ) using qBasePlus soft-
ware (Biogazelle NV, Zwijnaarde, Belgium) [18]. Its algorithm
uses gene-specific amplification efficiency values and allows
normalization with multiple reference genes. Mean values from
both RT-qPCR for each sample was considered for statistical
evaluation.C
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Fig. 1. Absolute expression values of the three reference genes in all the
samples of the study. Mean values: A) CFTR-wild type RT1=24.98,
RT2=25.00; CFTR-splicing RT1=25.01, RT2=24.71; B) CFTR-wild type
RT1=24.69, RT2=24.42; CFTR-splicing RT1=24.48, RT2=24.35; C) CFTR-
wild type RT1=27.04, RT2=26.54; CFTR-splicing RT1=27.12, RT2=26.62.
RT1 (circle); RT2 (triangle).2.5. Statistical analysis
A Mann–Whitney test using SPSS 12.0 (SPSS Software,
Chicago, IL, USA) was applied to evaluate differential expression
between groups. Differences were considered statistically signif-
icant when pb0.05.
To assess the stability of candidate reference genes two
different softwares, geNorm and NormFinder, were applied.
GeNorm software [9] calculates the gene expression stability
value M as the average pair wise variation of a particular gene
compared with all other candidate reference genes (RQ values).
Additionally, geNorm also determines the optimal number of
genes to an accurate normalization. All genes with an M
valueb0.5 are considered stable. A coefficient of variation
(CV) from normalized data, is also determined providing a
measure of expression dispersion (cutoff valueb0.200). In the
NormFinder program [19] the stability value is based on the
combined estimate of intra- and inter-group expression
variations (Cq values) for each candidate reference gene. A
low stability value indicates a low combined intra and inter-
group variation and proves high expression stability. Using thismeasure, the most stable gene and the best combination of two
genes for data normalization are calculated.
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3.1. Absolute gene expression
We analyzed the transcript abundance of all four genes in
the three different cell types, HEK 293-CFTR, NP and NE
(pool of control samples), by direct comparison of their Cq
values. The PCR efficiency and the expression profile were
determined for each single gene assay using the calibration
curves (Table 2). Efficiency for each candidate reference gene
ranged from 1.853 to 1.901 and their correlation coefficients
(R2) ranged from 0.986 to 0.997.
The B2M gene showed a similar expression profile in HEK
293-CFTR and NP. In addition, when the B2M expression
profile was compared with the corresponding expression of
remaining genes in NP, it showed the highest expression level
(i.e., 16.0–26.4 vs. 26.4–34.5 in CFTR). Such different
expression behavior was considered enough to exclude B2M
for further analysis. As expected, CFTR gene expression was
higher in HEK 293-CFTR compared to NP and NE, because of
its CFTR over-expression. The comparison of the Cq values
between nasal tissues resulted in a similar expression level
(GUSB, ATB2B4) or lower (HPRT1, CFTR) in NE than in NP
(Table 2).
3.2. Candidate genes analysis
First, the mean value of raw Cq values from RT1 and RT2
were analyzed in a pilot study, CFTR-wt controls (n=7) and
CFTR-splicing group (n=9), using the Mann–Whitney test,
which showed no statistically significant differences between
groups for the three candidate genes (p=0.606 for GUSB and
ATP2B4; p=0.408 for HPRT1).
Then, gene stability was assessed by two different programs.
The NormFinder software ranked HPRT1 as the most stable
gene (0.083) and HPTR1 and ATP2B4 as the best combination
of two genes for target gene data normalization (0.093).
Individually, GUSB and ATP2B4 presented a Normfinder
stability value of 0.150 and 0.153, respectively.
On the other hand, the geNorm software showed an M value
higher than 0.5 for all three genes analyzed (GUSB, 0.571;
ATP2B4, 0.596; HPRT1, 0.787). CV analysis that resulted from
the application of this software also determined that GUSB
and HPRT1 were above the cutoff value, 0.200 and 0.453Table 2
Calibration curve intervals and efficiencies of all genes analyzed in the three cell ty
Sample CFTR GUSB ATP2B
Interval Efﬁciency Interval Efﬁciency Interva
HEK 293 a 16.8–24.6 1.879 22.2–29.6 1.867 25.1–3
NP 26.4–34.5 1.875 22.1–31.8 1.901 23.1–3
NE 28.4–36.3 1.883 23.9–31.8 1.884 23.5–3
NP, nasal polyp; NE, nasal epithelium (pool of control samples); nd, not determined
Expression interval data expressed as Cq values.
Efficiency value was obtained from each calibration curve (maximum efficiency va
a HEK 293 cell line over-expressing wild type CFTR cDNA.respectively. Therefore, the combination of the three genes was
considered unstable. However, when the gene showing greater
M value (HPRT1) was omitted from the analysis, the
combination of the two other genes was considered stable,
showing M and CV value into the range, M=0.354 CV=0.128
for GUSB; M=0.354 CV=0.119 for ATP2B4.
The Mann–Whitney test showed no statistically significant
differences between groups for any of the genes studied, when
the data were normalized with either the combination of three
genes (GUSB, 0.96±0.07 vs. 0.86±0.06, p=0.090; ATP2B4,
0.98±0.08 vs. 0.98±0.09, p=0.832; HPRT1, 1.02±0.13 vs.
1.20±0.09, p=0.203) or the combination of two genes (GUSB,
1.00±0.04 vs. 0.93±0.06, p=0.222; ATP2B4, 1.01±0.02 vs.
1.07±0.07, p=0.289; HPRT1, 1.03±0.20 vs. 1.32±0.14,
p=0.203).
To verify the discrepancies in gene stability found using
NormFinder and geNorm, a second study was conducted with a
greater number of samples, CFTR-wt controls (n=21) and
CFTR-splicing group (n=18). Differences in raw data between
both groups were again not statistically significant: GUSB,
p=0.791; ATP2B4, p=0.728; HPRT1, p=0.666 (Fig. 1).
Although NormFinder analysis again considered HPRT1
stable (0.006), it ranked GUSB as the most stable gene (0.003)
and identified GUSB and ATP2B4 as the best combination of
two genes for normalization (0.003). The corresponding geNorm
analysis showed the following values for each gene: HPRT1,
M=0.689 and CV=0.376; GUSB, M=0.537 and CV=0.220;
and ATP2B4, M=0.515 and CV=0.193, once more indicating
the combination of the expression of the three genes was
unstable. However, similarly to the first study, after HPRT1
exclusion, GUSB (M=0.363, CV=0.127) and ATP2B4
(M=0.363, CV=0.125) were considered suitable as normalizers.
The Mann–Whitney test again showed no statistically
significant differences between groups in this second study,
either for data normalized with the combination of the three
genes (GUSB, 0.95±0.09 vs. 0.99±0.14, p=0.662; ATP2B4,
0.98±0.08 vs. 0.98±0.11, p=0.535; HPRT1, 1.03±0.07 vs.
1.08±0.13 p=0.833) or when data were normalized using the
two gene combination (GUSB, 0.99±0.07 vs. 1.01±0.07,
p=0.573; ATP2B4, 1.01±0.06 vs. 1.02±0.07, p=0.526;
HPRT1, 1.05±0.10 vs. 1.13±0.20, p=0.866) (Fig. 2).
Overall, the second study supported the combination of
GUSB and ATP2B4 as a suitable normalizer for CFTR gene
expression in NE.pes.
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Fig. 2. Boxplot representation of reference gene expression variability for each
individual group in the second study for the three genes tested. Data
normalization was performed using a combination of three, GUSB, HPRT1
and ATP2B4 (A) and two, GUSB and ATP2B4, reference genes (B). Statistical
significant differences were not found among the level expression in both
groups. On the Y-axis gene expression is plotted. CNRQ median values and
absolute deviation of the median (MAD) are also shown. Statistical analysis was
performed using the Mann–Whitney test, considering pb0.05 statistically
significant.
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Relative quantification of transcript levels by RT-qPCR
relies on the simultaneous analysis of target and reference genes
to provide an accurate interpretation of results. Commonly used
reference genes (GAPDH, ACTB, TPB, 18s among others) have
often been adopted without assessing their specific tissue
dependent behavior or the study design [9,20,21]. Once
evaluated, some of these reference genes have shown variable
expression in different tissues and/or under different experi-
mental conditions [22,23]. Furthermore, most of them have
shown a higher expression than the target gene [11], which is
responsible for a significant bias concerning the interpretation
of results of the target gene. In addition, several authors have
demonstrated that the greater the number of reference genes
used, the more accurately transcript amount of a target gene
will be determined [9]. Therefore, validation of reference geneshas become a pre-requisite for reliable data normalization for
gene expression studies and the inclusion of more than one
reference gene is strongly recommended whenever possible.
Interestingly, guidelines for RT-qPCR gene expression analysis
have been published recently to highlight the different variables
involved and to show how to minimize their effect to improve
accuracy and reproducibility [7].
So far, major attention has been focused on reliable
reference genes to determine the profile of gene expression in
tumor tissues [19,24–26]. However, to our knowledge this is
the first study to evaluate reference genes for CFTR gene
expression quantification. Taking into account that gene
expression varies among the different tissues in an individual,
we have developed this study using NE samples due to the
accessibility of this sample commonly used in CFTR transcript
analysis. The aim of this work was to validate reference genes
for CFTR gene qPCR expression studies in NE tissue. To that
end, the expression of four candidate reference genes: B2M,
GUSB, HPRT1 and ATP2B4, has been analyzed.
For the present analytical strategy many factors that could
influence the final interpretation of results have been taken into
account to obtain homogeneous raw data. First, to reduce the
variability due to mRNA quality, NE brushing samples were
collected in the same CF Unit and treated equally along all the
steps of the process. The inclusion criteria applied also
contributed to the reduction of variability between samples
and its effect on results. Particularly, we included a RINN5,
without significant differences between the two CFTR groups
as an indicator of similar RNA quality for downstream
applications [8]. Secondly, to minimize the RT efficiency
variation, all samples were processed simultaneously in two
independent RT experiments.
Additionally, following guidelines for qPCR assays [7], the
study has comprised two independent RT/sample, triplicate
PCR reactions of each sample/gene, creation of calibration
curves and the inclusion of controls to validate the experiments.
The low CFTR gene expression in NE has been a key to create
calibration curves with only four dilution points taking into
account that a Cq above cycle 35 lacks reliability [27]. PCR
efficiency and gene expression estimation were measured from
calibration curves. In addition, the accuracy of the experiments
is supported by the raw Cq analysis and the inter- and intra-
assays CV (see Material and methods).
As expected, nasal samples (NP, NE) showed a significantly
lower CFTR gene expression level compared with the HEK
293-CFTR (Table 2). However, the high sensitivity of RT-
qPCR makes it able to reliably quantify the expression of genes
with a low transcript level. Minor differences were found
between NP and NE, supporting the suggestion that tissue
specific expression must be considered.
The first decision concerning reference genes was to rule out
the B2M as a candidate for normalization for CFTR gene
expression considering that its higher expression level (Table 2)
could lead to an erroneous interpretation of data of our target
gene as stated in the guidelines [7].
For the remaining candidate genes, as previously suggested
[28,29], several programs were applied to evaluate the
403L. Masvidal et al. / Journal of Cystic Fibrosis 11 (2012) 398–404expression stability of reference genes in the two studies carried
out (n=16 and n=39). The result of the expression stability
obtained from the geNorm software was independent of the
number of samples; both studies indicating the combination of
GUSB and ATP2B4 gene expression was suitable for data
normalization. Independently, the NormFinder program chan-
ged the gene ranking depending on the number of samples,
validating the same combination as geNorm once the number of
samples had been increased (second study).
Furthermore, the Mann–Whitney analysis showed no
statistical differences in the expression levels of candidate
genes between groups in either of the normalized studies, or in
raw data assessment, thus supporting their suitability as
reference genes (Fig. 2). However, comparing both analyses,
a lower dispersion was observed when data normalization was
performed using the best two in the ranking, reinforcing GUSB
and ATP2B4 as the best combination for gene expression
analysis in NE cells. This work does not rule out other putative
reference genes not tested here.
On the other hand, the study has demonstrated that, although
NE brushing provides a limited number of cells, this amount is
enough for simultaneous gene expression analysis of the CFTR
target and the two reference genes in duplicate.
In summary, we have developed the first validation study to
identify suitable reference genes for data normalization for CFTR
gene expression in NE cells by RT-qPCR. The present study
shows that the GUSB and ATP2B4 combination fulfills the
stability criteria and similar level expression between the
analyzed groups and accordingly, data normalization for CFTR
gene expression can be reliably determined using a combination
of these two reference genes. A main application of this study
concerns CFTR mutations affecting transcript amount as well as
therapies focused on this kind of mutations. Undoubtedly, the ex
vivo analysis of mRNA by RT-qPCR will contribute to a better
understanding of the relationship between CFTR transcript
quantity and its clinical outcomes in the different affected tissues.
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